Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Shingles vaccine programme proving effective but uptake falling


The benefits of the shingles vaccination programme need to be “effectively communicated” to health professionals and the public to reverse a fall in uptake, according to researchers.

The introduction of shingles vaccination in England has led to a “substantial” reduction in cases and long-term complications, according to the first evidence published on the impact of the programme.

“Communication of the public health impact will be important to reverse the recent trend of declining vaccine coverage”

Study authors

The herpes zoster vaccination programme was introduced in England in 2013 for adults aged 70 years, with a phased catch-up campaign for those aged 71–79 years.

To minimise workload in primary care, the programme is delivered in general practice alongside the seasonal influenza vaccination programme. The vaccine used is Zostavax, made by Merck.

The new study, carried out by researchers at Public Health England, shows a substantial decrease in shingles cases and associated complications in the first three years since the introduction of the immunisation programme.

The analysis of the programme estimated that the vaccine was 62% effective against shingles and 70-88% effective against post-herpetic neuralgia, or long-term pain – one of its main complications.

“Our population is aging and the risk from getting shingles and complications is higher as you get older”

Mary Ramsay

The study, published on Thursday in the Lancet Journal of Public Health, estimated that GP visits for shingles and associated neuralgia reduced by 35% and 50%, respectively, in those aged 70 during 2013 to 2016.

An estimated 17,000 GP visits for shingles were avoided among the 5.5 million individuals who were given the vaccination in the first 3 years of the programme across England, according to the study.

But, in spite of the “very positive” results, PHE noted that uptake of the vaccine had declined, with a 13% decline in people aged 70 since the start of the programme and an 8.4% decline in people aged 78 years since 2014.

The researchers said: “Despite the encouraging coverage early in the vaccination programme, coverage has declined by 6.9 percentage points since the start of the programme, from 61.8% in 2013-14 to 54.9% in 2015-16.

“Given the demonstrated impact of the programme on herpes zoster and postherpetic neuralgia, the benefits of the programme need to be effectively communicated to health professionals and the public to maximise protection from this potentially debilitating condition in those most at risk,” they said.

PHE noted that the shingles vaccination programme currently targeted adults aged 70 and 78 with a catch-up programme for those aged 71 to 79.

It said it was encouraging healthcare professionals and the public to be aware of the complications surrounding shingles and to encourage those within the eligible groups to get vaccinated.

Public Health England

Dr Mary Ramsay

Mary Ramsay

“It’s the best way to avoid this very nasty disease and the long-term complications that can develop from having it,” said Dr Mary Ramsay, head of immunisations at PHE and one of the study authors.

“Our population is aging and the risk from getting shingles and complications is higher as you get older,” she added.

Over 50,000 cases of shingles occur in people aged 70 years and over each year in England and Wales, with around 50 cases being fatal, according to data cited by PHE.

Shingles is characterised by a skin rash on one side of the body resulting from reactivation of chicken pox virus that has been lying dormant in the body.

It can last on average for two to four weeks and be significantly debilitating, causing loss of sleep and and interference with day-to-day activities. Symptoms can include sharp stabbing pain and burning of the skin in the affected area, feeling unwell, a bad headache and a fever.


Readers' comments (2)

  • Shingle vaccine uptake falling as we all know how benificial for the elderly. I came across some patients (over 70 years) came in requesting for the vaccine but was turned down because of the shingle program NHS which only given to those born after 1942 till age 80 yrs. but excluding those age (75 -77). The group (75-77) has to wait till 1st Sept when they turn 78yrs then they can have the vaccine. Surely everyone over 70yrs should have the vaccine. I came across a patient within that group (75-77) had contacted shingles as he was not entitled for Zostvax because he fell in that age group.

    Unsuitable or offensive? Report this comment

  • Herpes virus is never a stop to your life I was once there and I know exactly how it feels to be a carrier of the cruel virus and it was a very bitter experience and so I began to contemplate whether to take my life or not. God so kind, somehow I stumbled on this website and it was the beginning of my new joy. I was cleansed and now I am totally cured of the virus using remedy from them and I a. So glad

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.